AAAAAA
Results:
1-16
|
Results: 16
Authors:
CATO A
QIAN J
HSU A
VOMVOURAS S
PIERGIES AA
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND DIDANOSINE WHEN ADMINISTERED CONCURRENTLY TO HIV-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 18(5), 1998, pp. 466-472
Authors:
CATO A
CADY WW
SOLTANEK C
QASAWA B
CHANG M
STOLL R
Citation: A. Cato et al., EFFECT OF HEMODIALYSIS ON THE PHARMACOKINETICS OF 19-NOR-1-ALPHA,25-DIHYDROXYVITAMIN D-2, American journal of kidney diseases, 32(2), 1998, pp. 55-60
Authors:
CATO A
QIAN J
HSU A
LEVY B
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., MULTIDOSE PHARMACOKINETICS OF RITONAVIR AND ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1788-1793
Authors:
CATO A
GUSTAVSON LE
QIAN J
ELSHOURBAGY T
KELLY EA
Citation: A. Cato et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND TOLERABILITY OF TIAGABINE, Epilepsia, 39(1), 1998, pp. 43-47
Authors:
CATO A
CAVANAUGH J
SHI H
HSU A
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., THE EFFECT OF MULTIPLE DOSES OF RITONAVIR ON THE PHARMACOKINETICS OF RIFABUTIN, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 414-421
Authors:
CATO A
QASAWA B
CHANG M
SOLTANEK C
STOLL R
CADY W
Citation: A. Cato et al., LACK OF EFFECT OF HEMODIALYSIS ON PLASMA-CONCENTRATIONS OF 19-NOR-1-ALPHA,25-DIHYDROXY-VITAMIN D-2 (19-NOR) ALLOWS DOSE ADMINISTRATION WITHOUT REGARD TO DIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 2661-2661
Authors:
CATO A
CAO GL
HSU A
CAVANAUGH J
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., EVALUATION OF THE EFFECT OF FLUCONAZOLE ON THE PHARMACOKINETICS OF RITONAVIR, Drug metabolism and disposition, 25(9), 1997, pp. 1104-1106
Authors:
HOLDEN CA
FUSCALDO GF
JACKSON P
CATO A
SOUTHWICK GJ
HAUSER R
TEMPLESMITH PD
MCLACHLAN RI
Citation: Ca. Holden et al., FROZEN-THAWED EPIDIDYMAL SPERMATOZOA FOR INTRACYTOPLASMIC SPERM INJECTION, Fertility and sterility, 67(1), 1997, pp. 81-87
Authors:
CATO A
BUSCHEN C
AHMED A
CHANG M
LANNI C
AMDAHL M
KLEMZ M
STOLL R
Citation: A. Cato et al., THE PHARMACOKINETICS OF PARACALCIN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 95-95
Authors:
CATO A
Citation: A. Cato, INTERNATIONAL-ASSOCIATION-OF-MUSIC-LIBRARIES REPORTS -GROUP ON THE CORE-BIBLIOGRAPHIC-RECORD FOR MUSIC AND SOUND-RECORDINGS( WORKING), FON ART MUS, 43(2), 1996, pp. 208-209
Authors:
CATO A
QIAN J
CAROTHERS L
CARLSON G
LOCKE C
HSU A
GRANNEMAN R
LEONARD J
Citation: A. Cato et al., EVALUATION OF THE PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND DIDANOSINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 59-59
Authors:
CATO A
POLLACK GM
BROUWER KLR
Citation: A. Cato et al., AGE-DEPENDENT INTESTINAL-ABSORPTION OF VALPROIC ACID IN THE RAT, Pharmaceutical research, 12(2), 1995, pp. 284-290
Authors:
ASTIZ ME
RACKOW EC
STILL JG
HOWELL ST
CATO A
VONESCHEN KB
ULRICH JT
RUDBACH JA
MCMAHON G
VARGAS R
STERN W
Citation: Me. Astiz et al., PRETREATMENT OF NORMAL HUMANS WITH MONOPHOSPHORYL LIPID-A INDUCES TOLERANCE TO ENDOTOXIN - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 23(1), 1995, pp. 9-17
Authors:
GUSTAVSON LE
CATO A
GUENTHER HJ
CARLSON GF
WITT GF
CAO GX
QIAN JX
BOELLNER SW
SOMMERVILLE KW
Citation: Le. Gustavson et al., LACK OF CLINICALLY IMPORTANT DRUG-INTERACTIONS BETWEEN TIAGABINE AND CARBAMAZEPINE, PHENYTOIN, OR VALPROATE, Epilepsia, 36, 1995, pp. 159-160
Authors:
CATO A
QIAN JX
GUSTAVSON LE
SAULIS R
CARLSON GF
KELLY EA
RINGHAM GL
SOMMERVILLE KW
Citation: A. Cato et al., PHARMACOKINETICS AND SAFETY OF TIAGABINE IN SUBJECTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Epilepsia, 36, 1995, pp. 159-159
Authors:
BEER B
IENI JR
WU WH
CLODY D
AMORUSI P
ROSE J
MANT T
GAUDREAULT J
CATO A
STERN W
Citation: B. Beer et al., A PLACEBO-CONTROLLED EVALUATION OF SINGLE, ESCALATING DOSES OF CL-284,846, A NONBENZODIAZEPINE HYPNOTIC, Journal of clinical pharmacology, 34(4), 1994, pp. 335-344
Risultati:
1-16
|